Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,501 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03672136 | Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients | unknown | Phase 2 | 25 | Shandong Cancer Hospital and InstituteOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT03407300 | A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) Patients | unknown | Phase 2 | 80 | Haining Health-Coming Biotech Co., Ltd.OTHER | 1 | Sep 13, 2018 |
| NCT01407822 | Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer(EMERGING) | unknown | Phase 2 / Phase 3 | 72 | Guangdong Association of Clinical TrialsOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03664115 | Itraconazole in Non Small Cell Lung Cancer | unknown | Phase 2 | 60 | Ain Shams UniversityOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03108560 | Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer | unknown | N/A | 600 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT03509779 | Pronostic and Predictive Value of EMT in Localized Lung Cancer(TWISTlung) | unknown | — | 1,000 | European Georges Pompidou HospitalOTHER | 1 | Sep 6, 2018 | clinicaltrials |
| NCT01669707 | Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 60 | Beijing Chest HospitalOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT03523234 | Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage | unknown | N/A | 300 | Peng ZhangOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT03656393 | To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma(RCTACSCNSCLC) | unknown | Phase 3 | 48 | Shenzhen People's HospitalOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT03050047 | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 15 | BiocadINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03654027 | Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC | unknown | Phase 2 | 84 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 0 | Aug 31, 2018 | clinicaltrials |
| NCT03651219 | Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer | unknown | Phase 3 | 90 | Beijing Chest HospitalOTHER | 0 | Aug 29, 2018 | clinicaltrials |
| NCT02450656 | Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer(M14AFS) | unknown | Phase 1 / Phase 2 | 320 | The Netherlands Cancer InstituteOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT01842555 | Photodynamic Therapy (PDT) Oncology Registry(PDT Registry) | unknown | — | 1,000 | Main Line HealthOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT03645252 | Sequence of Vessel Interruption and Circulating Tumor Cells in Surgical Lung Cancer(CTC-01) | unknown | N/A | 30 | Laval UniversityOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT03641105 | Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma | unknown | — | 100 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 21, 2018 | clinicaltrials |
| NCT03636685 | Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC | unknown | Phase 1 / Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 0 | Aug 17, 2018 | clinicaltrials |
| NCT03480230 | Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer | unknown | Phase 2 | 60 | Arafat TfayliOTHER | 2 | Aug 14, 2018 | clinicaltrials |
| NCT03628521 | First-line Combination Treatment Based on Anlotinib | unknown | Phase 1 | 80 | Shanghai Chest HospitalOTHER | 1 | Aug 14, 2018 | clinicaltrials |
| NCT03616691 | Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC | unknown | Phase 2 | 46 | Samsung Medical CenterOTHER | 0 | Aug 6, 2018 | clinicaltrials |
| NCT03614065 | Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC | unknown | Phase 2 | 50 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT03601598 | A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC | unknown | Phase 1 / Phase 2 | 41 | Harbin Medical UniversityOTHER | 0 | Jul 26, 2018 | clinicaltrials |
| NCT03602027 | Phase I Study of the Combination of Anlotinib With Gefitinib | unknown | N/A | 9 | Second Affiliated Hospital of Nanchang UniversityOTHER | 0 | Jul 26, 2018 | clinicaltrials |
| NCT02507518 | Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer(CALMETTE) | unknown | Phase 2 | 80 | Centre Henri BecquerelOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT03594682 | Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study | unknown | N/A | 31 | Beijing Chest HospitalOTHER | 0 | Jul 20, 2018 | clinicaltrials |
| NCT03396185 | Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 18, 2018 | clinicaltrials |
| NCT02433574 | Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection(LINNEARRE-I) | unknown | N/A | 20 | Juravinski Cancer CenterOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT03410368 | NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. | unknown | Phase 2 | 120 | jiuwei cuiOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT03583723 | Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial)(LARTIA) | unknown | N/A | 50 | Campus Bio-Medico UniversityOTHER | 1 | Jul 12, 2018 | clinicaltrials |
| NCT02980536 | cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China | unknown | — | 129 | Berry Genomics Co., Ltd.INDUSTRY | 1 | Jul 11, 2018 | clinicaltrials |
| NCT02655536 | Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial(BRILLIANT) | unknown | Phase 2 | 109 | National Taiwan University HospitalOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03533127 | A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 3 | 648 | Luye Pharma Group Ltd.INDUSTRY | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03566576 | Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel | unknown | N/A | 18 | Fujian Cancer HospitalOTHER_GOV | 0 | Jun 25, 2018 | clinicaltrials |
| NCT03560362 | Postoperative Pain Control With Lipossomic Extended Release Bupivacaine | unknown | Phase 1 / Phase 2 | 50 | University of TennesseeOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT03546452 | A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC | unknown | — | 50 | Shanghai Chest HospitalOTHER | 1 | Jun 7, 2018 | clinicaltrials |
| NCT02956551 | Personalized DC Vaccine for Lung Cancer(SKLB1608) | unknown | Phase 1 | 20 | Sichuan UniversityOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT03527251 | Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC(SEQUENCE) | unknown | Phase 1 | 10 | Sun Yat-sen UniversityOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03523611 | Right Ventricular Inflammation After Lung Resection | unknown | — | 15 | University of GlasgowOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT02696525 | Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients | unknown | — | 145 | Peking University People's HospitalOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT03525782 | Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC | unknown | Phase 1 / Phase 2 | 60 | The First Affiliated Hospital of Guangdong Pharmaceutical UniversityOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03522090 | Retrospective Comparative Study of Routine Lower Neck CT in the Staging and Diagnosis of Lung Cancer Across Two Cohorts | unknown | — | 164 | University College Hospital GalwayOTHER | 0 | May 11, 2018 | clinicaltrials |
| NCT03512015 | A Mobile Supportive Care App for Patients With Metastatic Lung Cancer(LuCApp) | unknown | N/A | 120 | Bocconi UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT02884479 | An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study | unknown | Phase 1 / Phase 2 | 75 | SciClone Pharmaceuticals International (Cayman) Development LimitedINDUSTRY | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02134990 | Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer | unknown | Phase 2 | 20 | Oshadi Drug AdministrationINDUSTRY | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01807390 | Perspectives of Receiving Open Versus Minimally Invasive Surgery(PROMIS) | unknown | — | 200 | Ottawa Hospital Research InstituteOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT03498768 | Epidemiology and Psychosocial Evaluation of Inpatient With Lung Opacity | unknown | — | 300 | Peking University People's HospitalOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02294578 | Salivary Biomarkers for Non-small Cell Lung Cancer Detection | unknown | — | 166 | PeriRxINDUSTRY | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03228056 | Postoperative Pain After Single Port, Two Ports and Three Ports VATS Lobectomy | unknown | N/A | 90 | Pulmonary Hospital ZakopaneOTHER | 1 | Apr 11, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Sep 14, 2018source: clinicaltrials